Quipt Home Medical Corp. confirmed receipt of another unsolicited, non-binding, and indicative proposal from Forager Capital Management, LLC (FCM), dated August 25, 2025. The proposal offered to acquire all outstanding common shares for US$3.10 per share.
Quipt's Board of Directors unanimously rejected the offer, denouncing it as "inferior" and "undervalued." The Board stated the proposal is not in the best interests of the Company or its shareholders.
The Board further criticized Forager's "self-serving tactics" and "misleading statements," reiterating its commitment to its strategic plan to drive long-term value. This rejection signals a firm stance against the proposed acquisition.
The Board's strong opposition indicates a potential for continued conflict with a major shareholder. This situation could create uncertainty for investors regarding the company's future direction and potential for a sale.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.